SinDuda: a community-drivenapproach to expandreach,access and uptake of COVID-19home-basedtests for at riskLatinos
Project Number1U01MD017412-01
Former Number1U01MH129890-01
Contact PI/Project LeaderPAGE, KATHLEEN R Other PIs
Awardee OrganizationJOHNS HOPKINS UNIVERSITY
Description
Abstract Text
The COVID-19 pandemic disproportionately impacts Latinos in the US. COVID-19 testing remains critical for
tracking and slowing the spread of the virus and preventing future outbreaks, particularly in communities
disproportionately affected by COVID-19 and where vaccination coverage is suboptimal. The goal of this
project is to expand our RADx-UP Phase 1 COVID-19 testing project "Vive Sin Duda" to implement and
evaluate innovative implementation strategies to increase reach,access, and uptake of COVID-19 homebased self-testing (HST) among low-income Latinos in Maryland. We will implement and evaluate two COVID19 HST distribution approaches: 1) Network-based; and 2) Social marketing. We will also incorporate data driven iterative changes to optimize a community health worker (CHW)-led short message service (SMS)
platform to support HST and linkage to COVID-19 care, vaccination, and other services (e.g., cash and food
assistance). Primary and secondary outcomes include: 1) Reach and uptake of HST; and 2) Linkage to care
for those who test positive or vaccination for unvaccinated people who test negative. Leveraging our existing
community coalition, testing and vaccination clinics, and a team of bilingual and bicultural CHWs, we are well poised to implement a COVID-19 HST program and measure its impact. Our research will provide important
new information that will improve access and uptake of innovative COVID-19 testing technology. It also will fill
critical knowledge gaps to guide the translation of evidence-based interventions into widespread adoption by
RADx-UP consortium members.
Public Health Relevance Statement
PROJECT NARRATIVE
The proposed study is relevant to profound disparities in COVID-19 among Latinos communities. This proposal
will implement and evaluate innovative implementation strategies to increase reach,access, and uptake of
COVID-19home-based self-testing (HST) among low-income Latinos in Maryland. This proposal provides
important new information that will improve access and uptake of innovative COVID-19 testing technology.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdherenceAdoptionAppointmentBaltimoreCOVID-19COVID-19 disparityCOVID-19 impactCOVID-19 pandemicCOVID-19riskCOVID-19 testCOVID-19 testingCOVID-19 vaccinationCOVID-19 vaccineCaringCitiesClinicCodeCommunicationCommunitiesCommunity Health AidesCommunity OutreachConsolidated Framework for Implementation ResearchDataDiagnostic Reagent KitsDisease OutbreaksEconomicsEquipment and supply inventoriesEvidence based interventionFDA Emergency Use AuthorizationFoodFutureGoalsGovernmentHealthHealth InsuranceHealth care facilityHealth systemHealthcareHomeHotlinesImmigrantImmigrationImprove AccessIndividualInstitutionInstructionInterviewKnowledgeLanguageLatinoLatino PopulationLibrariesLimited English ProficiencyLinguisticsLinkLow incomeMarylandMeasuresMedia CampaignNatureNetwork-basedNot Hispanic or LatinoParticipantPatient RecruitmentsPersonsPhasePreventivePrivatizationProtocols documentationRADx Underserved PopulationsReach Effectiveness Adoption Implementation and MaintenanceResearchRiskSARS-CoV-2 positiveSelf AdministrationServicesSiteSocial MarketingSocial WorkStructureTechnologyTestingText MessagingTimeTrainingTranslationsTrustUncertaintyVaccinationVirusbasebilingualismcommunity cliniccommunity organizationshome testimplementation determinantsimplementation outcomesimplementation processimplementation strategyindexinginnovationmemberphase 1 testingpreventprimary outcomeprogramssecondary outcomeself testingsocialsocial mediasocial stigmasocial vulnerabilitytesting uptaketransmission processunvaccinateduptakeusabilityweb site
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
001910777
UEI
FTMTDMBR29C7
Project Start Date
01-January-2022
Project End Date
30-November-2023
Budget Start Date
01-January-2022
Budget End Date
30-November-2022
Project Funding Information for 2022
Total Funding
$1,238,301
Direct Costs
$770,386
Indirect Costs
$467,915
Year
Funding IC
FY Total Cost by IC
2022
NIH Office of the Director
$1,238,301
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U01MD017412-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01MD017412-01
Patents
No Patents information available for 1U01MD017412-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01MD017412-01
Clinical Studies
No Clinical Studies information available for 1U01MD017412-01
News and More
Related News Releases
No news release information available for 1U01MD017412-01
History
No Historical information available for 1U01MD017412-01
Similar Projects
No Similar Projects information available for 1U01MD017412-01